Highlights
NASDAQ: IMDZ       Immune Design CS
Last Price Today's Change   Day's Range   Trading Volume
5.84   -0.01 (0.17%)  5.83 - 5.85  149,321

Overview

 
Avg Volume (4 weeks):2,644,678
4 Weeks Range:1.36 - 5.85
4 Weeks Price Volatility (%):
99.78%
52 Weeks Range:1.10 - 5.85
52 Weeks Price Volatility (%):
99.79%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Immune Design is a clinical-stage immunotherapy company. Its focus is next-generation in vivo methods intended to enable the body’s immune system to fight diseases. The company’s therapies have a broad potential approach across multiple therapeutic areas. Nevertheless, the company’s target is oncology, and it is developing tumor-specific cytotoxic T cells to fight cancer. The main discoveries are CMB305 and G100, immuno-oncology approaches that are believed to address the shortcomings of existing oncological therapies.

  Be the first to like this.
 


 

2618  5042  410  642 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMD 25.675-0.325 
 SGYP 0.03-0.033 
 TAHO 3.64-0.15 
 NVAX 0.644+0.092 
 CHK 3.31+0.15 
 ACB 9.625-0.335 
 F 8.535-0.165 
 SPY 281.16-1.24 
 NIO 5.815-0.145 
 EEM 43.34-0.24 
Partners & Brokers